Eli Lilly and Alexandria Real Estate Equities Open New San Diego Facility Through Gateway Labs Partnership

Eli Lilly has partnered with Alexandria Real Estate Equities to open a new Gateway Labs facility in San Diego. The facility will serve as a hub for the company's research and development efforts. The partnership aims to leverage Eli Lilly's scientific expertise and Alexandria's real estate expertise to create an environment conducive to innovation. The facility is expected to support Eli Lilly's efforts to develop new treatments for various diseases.

Eli Lilly and Company (NYSE: LLY) and Alexandria Real Estate Equities (NYSE: ARE) have announced the opening of a new Gateway Labs facility in San Diego, California. The strategic partnership aims to leverage Eli Lilly's scientific expertise and Alexandria's real estate infrastructure to create an environment conducive to innovation in biotechnology.

The new Gateway Labs site, located on the One Alexandria Square Megacampus in Torrey Pines, features 82,514 square feet of flexible laboratory and office space designed to accommodate up to 15 life sciences companies and more than 250 employees Lilly opens newest Gateway Labs site in San Diego to boost local biotechnology ecosystem^[1]. The facility is equipped with advanced scientific equipment and collaboration spaces, providing a state-of-the-art environment for early-stage biotech companies.

The Gateway Labs model offers startups access to wet lab facilities, tailored scientific engagement, and strategic guidance to help navigate the complexities of drug discovery and development. Since the first Gateway Labs site opened in 2019, LGL-based companies have raised over $2 billion in capital, supporting the development of more than 50 therapeutics and platforms currently in progress Lilly opens newest Gateway Labs site in San Diego to boost local biotechnology ecosystem^[1].

The partnership between Eli Lilly and Alexandria Real Estate Equities represents a significant expansion of the Gateway Labs platform. The new facility combines Alexandria's real estate infrastructure and operational expertise with Lilly's scientific resources, mentorship, and venture capital network. Initial tenants include venture-backed biotech companies focusing on Alzheimer's, Parkinson's, cardiovascular diseases, and oncology research Alexandria Real Estate Equities, Inc. Strategically Partners With Lilly on Newest Lilly Gateway Labs at the One Alexandria Square Megacampus in San Diego's Torrey Pines to Accelerate the Development of Life-Changing Medicines^[2].

The opening of the new Gateway Labs site in San Diego is expected to support Eli Lilly's efforts to develop new treatments for various diseases. The facility will also enhance Alexandria's tenant offering, potentially increasing occupancy rates and rental premiums at the One Alexandria Square Megacampus.